Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Altimmune, Inc. (ALT) Institutional Ownership & Insider Trading

210 institutions reported holding Altimmune, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 11 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ALTAltimmune, Inc.Follow ALT — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
412.4M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
10 Nov, in 17 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

210 institutions held 77.9% of the shares. Across filers that reported both quarters, shares held changed +118.7%.

Increased+85New+54Decreased-31Closed-14

Largest moves, shares (millions)

Deep Track Capital+19.3MTCG Crossover Management+10.0MBlackRock+7.6MAlyeska Investment Group-2.6MSchroder Investment…-0.7MSusquehanna International…-0.6M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-4.2Sep 24+0.9Dec 24-2.4Mar 25-0.6Jun 25+4.0Sep 25+13.1Dec 25+12.7Mar 26+82.3Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26210152+118.7%85543114
Mar 2617169+28.4%78243431
Dec 2518155+33.8%70422220
Sep 2515542+10.7%53194637
Jun 2517937-1.7%67333929
Mar 2517238-6.1%53224825
Dec 2418040+2.3%61263918
Sep 2416639-11.0%53194123

Altimmune, Inc. — questions

Who owns Altimmune, Inc. stock?
210 institutions reported Altimmune, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (10.5%), Deep Track Capital, LP (9.9%), STATE STREET CORP (6.2%).
Are Altimmune, Inc. insiders buying or selling?
11 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Altimmune, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.